Fatty Liver Disease: Why Early Detection Matters More Than Ever
- Emily Lee

- Jun 22
- 5 min read
Updated: Jun 25
Do you enjoy a glass of wine to unwind at the end of the day, but secretly wonder how much is actually safe for your liver?
This is one of the most common questions I get in the clinic.
The truth is, how your liver handles alcohol is deeply connected to your overall metabolic health. Your diet, lifestyle, and even your genetics all play a huge role in your liver's resilience. Surprisingly, standard routine blood tests can often completely miss the early signs that your liver is feeling the strain.
The liver is one of the hardest-working organs in the body. It filters toxins, regulates blood sugar, metabolises hormones, processes nutrients, and supports digestion. Yet liver disease often develops silently, with many people unaware that damage is occurring until it has progressed significantly.
In recent years, medical terminology around fatty liver disease has changed. The term Non-Alcoholic Fatty Liver Disease (NAFLD) has largely been replaced by Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), while alcohol-related fatty liver disease is now referred to as Alcohol-Related Liver Disease (ARLD).
Both conditions involve excess fat accumulation within liver cells, but their underlying drivers can differ.
Whether driven by diet, alcohol, or a combination of both, steatosis (fat accumulation in liver cells) is a reversible condition in its early stages. From a clinical perspective, addressing it requires moving beyond isolated symptom management to target the underlying physiological drivers.

What is MASLD?
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) occurs when fat accumulates in the liver alongside metabolic dysfunction.
Key Drivers: Insulin resistance, Type 2 diabetes, obesity, high blood pressure, and PCOS.
Important Note: You do not have to be overweight to develop MASLD. Lean individuals can also develop it due to poor diet, chronic stress, or genetics.
What is ARLD?
Alcohol-Related Liver Disease (ARLD) develops from excessive alcohol consumption. The liver prioritizes metabolizing alcohol, which impairs fat breakdown and triggers heavy inflammation. While early-stage ARLD is reversible, ongoing alcohol intake can lead to irreversible cirrhosis.
What Causes Fatty Liver?
Fatty liver is rarely caused by a single factor. It is typically a combination of the following drivers:
Category | Common Contributors |
Dietary | High intake of refined carbs, fructose, and excess calories; low fiber intake. |
Lifestyle | Sedentary habits, poor sleep quality, chronic stress, and heavy alcohol use. |
Medical / Hormonal | Insulin resistance, metabolic syndrome, PCOS |
Gut Health | Gut dysbiosis and increased intestinal permeability (the gut-liver axis). |
Clinical Presentation and Symptoms
In its initial stages, steatotic liver disease is notoriously silent, often identified incidentally through elevated liver enzymes (ALT, AST, GGT) on a routine blood panel or via ultrasound. When symptoms do manifest, they typically present as:
Chronic lethargy and generalized fatigue
Unexplained weight loss
A dull ache or discomfort in the right upper quadrant of the abdomen
Cognitive blunting, brain fog, or sleep disturbances
In alcohol-associated cases, mild jaundice or fluid retention may appear as the condition advances
Risks Associated with Fatty Liver Disease
Fatty liver disease increases the risk of several health issues:
Liver inflammation and scarring: Can lead to non-alcoholic steatohepatitis (NASH), a more serious form.
Cirrhosis: Permanent liver damage that impairs function.
Liver cancer: Risk rises with ongoing liver damage.
Cardiovascular disease: Fatty liver often coexists with heart disease risk factors like high cholesterol and hypertension.
Type 2 diabetes: Insulin resistance linked to fat buildup in the liver.
People with obesity, type 2 diabetes, high cholesterol, or metabolic syndrome have a higher chance of developing fatty liver disease.
The Diagnostic Gap: Why Normal Blood Tests Aren't Enough
Many people assume that normal liver function tests (ALT, AST, GGT, ALP) mean their liver is perfectly healthy. This is a dangerous misconception. Standard blood tests can remain within normal ranges despite significant fat accumulation in the liver. Relying solely on blood work can provide a false sense of security.
Why Ultrasound is Recommended: An abdominal ultrasound is the gold standard for early detection. It can identify structural changes, liver size, and excess fat before enzymes elevate. If you have risk factors like insulin resistance or regular alcohol intake, an ultrasound provides a much clearer clinical picture.
Early Intervention Can Reverse It
The liver has a remarkable regenerative capacity. When the underlying drivers are addressed early, fatty liver is highly reversible.
Core Nutrition Strategies
Prioritize Whole Foods: Focus on vegetables, legumes, lean proteins, nuts, seeds, and extra virgin olive oil.
Increase Fiber: Oats, whole grains, and vegetables support blood sugar regulation and gut health.
Support Protein Intake: Adequate protein preserves muscle mass and improves insulin sensitivity.
Dramatically Reduce Refined Carbs: Cut back on sugary drinks, juices, baked goods, and highly processed snacks.
Reduce Alcohol Consumption: Reducing or completely stopping alcohol consumption is one of the single most effective ways to support, protect, and restore liver function
Core Lifestyle Strategies
Move Regularly: Aim for 150 minutes of moderate aerobic activity and 2–3 resistance training sessions weekly to burn liver fat.
Prioritize Sleep: Secure 7–9 hours of quality sleep to combat insulin resistance.
Manage Stress: Utilize mindfulness, breathwork, or time in nature to lower cortisol and systemic inflammation.
Evidence-Informed Nutritional Support
While diet and lifestyle are the foundation, targeted nutraceuticals can accelerate healing. (Always consult your Naturopath before starting supplements, especially if you have existing liver disease).
Nutrient / Herb | Clinical Benefit |
Omega-3 Fatty Acids | Reduces liver fat accumulation and systemic inflammation. |
Milk Thistle | Contains silymarin, a powerful hepatoprotective and antioxidant compound. |
Green Tea Extract | Rich in catechins to support fat metabolism. |
Choline | Essential for transporting fat out of the liver. |
Herbal Digestives | Dandelion root, globe artichoke, and ginger support bile flow and digestion. |
Practical Tips for Daily Life
Prepare meals at home to control ingredients and make healthier choices.
Swap sugary beverages for water, herbal teas, or infused water.
Plan regular physical activity, such as walking, cycling, or swimming.
Monitor your weight and health markers with your doctor.
Consider ultrasound screening to detect disease early
Avoid crash diets or rapid weight loss, which can worsen liver damage.
Taking small, consistent steps can make a big difference in preventing or managing fatty liver disease.
Boon a Consultation
If you’re ready to prioritize your long-term health and find a rhythm that feels good, I invite you to reach out and let's get started on your natural health journey today.
Reference
Akhlaghi, M., Ghasemi-Nasab, M., Riasatian, M. and Sadeghi, F. (2020) 'Mediterranean diet for patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of observational and clinical investigations', Clinical Nutrition ESPEN, 37, pp. 67–77.
Fracanzani, A.L., Burdick, L., Raselli, S., Pedotti, P., Grigore, L., Santorelli, G., Valenti, L. and Fargion, S. (2008) 'Carotid artery intima-media thickness in nonalcoholic fatty liver disease', American Journal of Medicine, 121(1), pp. 72–78.
Hernaez, R., Lazo, M., Bonekamp, S., Kamel, I., Brancati, F.L., Guallar, E. and Clark, J.M. (2011) 'Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis', Hepatology, 54(3), pp. 1082–1090.
Orci, L.A., Gariani, K., Oldani, G., Delaune, V., Morel, P., Toso, C. and Negro, F. (2016) 'Exercise-based interventions for non-alcoholic fatty liver disease: A meta-analysis and meta-regression', Clinical Gastroenterology and Hepatology, 14(10), pp. 1398–1411.
Panahi, Y., Kianpour, P., Mohtashami, R., Jafari, R., Simental-Mendía, L.E. and Sahebkar, A. (2017) 'Efficacy and safety of phytosomal curcumin in non-alcoholic fatty liver disease: A randomized controlled trial', Drug Research, 67(4), pp. 244–251.
Rinella, M.E., et al. (2024) 'AASLD Practice Guidance on the clinical assessment and management of metabolic dysfunction-associated steatotic liver disease (MASLD)', Hepatology, 79(1), pp. 1–63.
Wah Kheong, C., Nik Mustapha, N.R., Mahadeva, S. and Chan, W.K. (2017) 'Silymarin for the treatment of non-alcoholic steatohepatitis: A systematic review and meta-analysis', Clinical Nutrition, 36(6), pp. 1384–1390.
Yan, J.H., Guan, B.J., Gao, H.Y. and Peng, X.E. (2018) 'Omega-3 polyunsaturated fatty acid supplementation and non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials', Medicine, 97(37), e12271.




Comments